LifeStance Health Group, Inc. — Form 8-K Summary
Business Context and Reporting Period
LifeStance Health Group, Inc. filed this Current Report on Form 8-K regarding its annual meeting of stockholders held on June 1, 2023. The filing reports voting results under Item 5.07 and does not provide operating or financial results for a reporting period.
Financial and Operating Metrics
The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, patient activity, or other financial metrics.
Material Changes and Corporate Actions
- Stockholders elected Darren Black, Eric Shuey, and Robert Bessler, M.D. as Class II directors for three-year terms.
- PricewaterhouseCoopers LLP was ratified as the company’s independent registered public accounting firm for the year ending December 31, 2023.
- Director election results included 28,968,187 broker non-votes for each nominee. Votes for each nominee were 252,313,764 for Darren Black, 270,607,447 for Eric Shuey, and 270,587,609 for Robert Bessler, M.D.
- The auditor ratification received 325,318,177 votes for, 81,476 against, and 285,871 abstentions.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no management guidance, outlook, risk update, contingency disclosure, or unusual financial item. It identifies LifeStance as an emerging growth company.
Facts for Investors to Verify
- Confirm the elected directors’ continued service and applicable board-class terms.
- Review subsequent filings for any changes to the board or committee composition.
- Verify PwC’s auditor appointment and review later financial filings for the year ending December 31, 2023.
- Consult the company’s periodic reports for financial performance, liquidity, debt, guidance, and risk information not included in this 8-K.